Literature DB >> 2372236

Effects of MEK on kinetics of n-hexane metabolites in serum.

E Shibata1, J Huang, N Hisanaga, Y Ono, I Saito, Y Takeuchi.   

Abstract

The neurotoxicity of n-hexane is thought to be caused ultimately by 2,5-hexanedione (2,5-HD), one of the n-hexane metabolites. The potentiation of n-hexane neurotoxicity by co-exposure with MEK, therefore, is suspected to be related to kinetics of 2,5-HD in blood. To clarify the kinetics of n-hexane metabolites in the mixed exposure of n-hexane and MEK, rats were exposed to 2000 ppm n-hexane or a mixture of 2000 ppm n-hexane and 2000 ppm MEK, and the time courses of serum n-hexane metabolites were determined. 2,5-HD in serum increased until 2 h after the end of exposure, when serum 2,5-HD concentration reached a peak of 16.35 micrograms/ml in the n-hexane-alone group. In contrast, 2,5-HD in the mixed exposure group increased much more slowly during and after exposure than in the n-hexane-alone group. It reached a peak of 2.12 micrograms/ml at 8 h after the end of exposure. Serum MBK, a precursor of 2,5-HD in the co-exposure group, was about half in the n-hexane-alone group during exposure. However, MBK decreased more slowly in the co-exposure group than in the n-hexane-alone group after the end of the exposure. The results suggest that co-exposed MEK might inhibit oxidation of n-hexane and decrease clearance of n-hexane metabolites. Co-exposed MEK did not increase serum 2,5-HD, which was considered a main neurotoxic metabolite. Therefore the enhancement of neurotoxicity could not be attributed to increased serum 2,5-HD in the co-exposed group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372236     DOI: 10.1007/bf02010732

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  14 in total

1.  The influence of inhaled ketone solvent vapors on hepatic microsomal biotransformation activities.

Authors:  D Couri; L B Hetland; S Abdel-Rahman; H Weiss
Journal:  Toxicol Appl Pharmacol       Date:  1977-08       Impact factor: 4.219

2.  Biotransformation of n-hexane and methyl n-butyl ketone in guinea pigs and mice.

Authors:  D Couri; M S Abdel-Rahman; L B Hetland
Journal:  Am Ind Hyg Assoc J       Date:  1978-04

3.  Dose-dependent uptake, distribution, and elimination of inhaled n-hexane in the Fischer-344 rat.

Authors:  T S Baker; D E Rickert
Journal:  Toxicol Appl Pharmacol       Date:  1981-12       Impact factor: 4.219

4.  Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine.

Authors:  L Perbellini; F Brugnone; I Pavan
Journal:  Toxicol Appl Pharmacol       Date:  1980-04       Impact factor: 4.219

5.  Changes in urinary n-hexane metabolites by co-exposure to various concentrations of methyl ethyl ketone and fixed n-hexane levels.

Authors:  E Shibata; J Huang; Y Ono; N Hisanaga; M Iwata; I Saito; Y Takeuchi
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

6.  Changes of n-hexane metabolites in urine of rats exposed to various concentrations of n-hexane and to its mixture with toluene or MEK.

Authors:  M Iwata; Y Takeuchi; N Hisanaga; Y Ono
Journal:  Int Arch Occup Environ Health       Date:  1983       Impact factor: 3.015

7.  The relevance of 4,5-dihydroxy-2-hexanone in the excretion kinetics of n-hexane metabolites in rat and man.

Authors:  N Fedtke; H M Bolt
Journal:  Arch Toxicol       Date:  1987-12       Impact factor: 5.153

8.  Relation between schedules of exposure to hexane and plasma levels of 2,5-hexanedione.

Authors:  R A Howd; L R Bingham; T M Steeger; C S Rebert; G T Pryor
Journal:  Neurobehav Toxicol Teratol       Date:  1982 Jan-Feb

9.  An experimental study of the combined effects of n-hexane and methyl ethyl ketone.

Authors:  Y Takeuchi; Y Ono; N Hisanaga; M Iwata; M Aoyama; J Kitoh; Y Sugiura
Journal:  Br J Ind Med       Date:  1983-05

10.  Changes of n-hexane neurotoxicity and its urinary metabolites by long-term co-exposure with MEK or toluene.

Authors:  M Iwata; Y Takeuchi; N Hisanaga; Y Ono
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.